Repeated human leukocyte antigen mismatches in lung re-transplantation

Transpl Immunol. 2017 Feb:40:1-7. doi: 10.1016/j.trim.2016.12.001. Epub 2016 Dec 5.

Abstract

Background: The role of HLA-sensitization in the absence of detectable DSA in lung re-transplantation is unclear. Antigens of the second donor matching the HLA typing of the first donor are considered 'unacceptable', by some tissue typing laboratories, especially in kidney re-transplantation.

Methods: Thus, we performed a retrospective analysis of all lung re-transplantations focussing on the impact of HLA-homologies between the first and the second donor ('unacceptable' antigens; repeated HLA mismatch) on patient and graft survival.

Results: A total of 132 lung re-transplantations were performed at our centre between 1985 and 2014, of which 120 with complete HLA data were analysed. 55.8% of the recipients received re-transplants with repeated HLA mismatched antigens whereas 43.2% of the re-transplants were transplanted without repeated HLA mismatched antigens. Postoperative survival showed no difference between re-transplant procedures with or without repeated HLA mismatches (p=0.99). While neither homologies on the HLA-A, -B, -C, or -DR locus, nor the addition of several locus homologies (p=0.72) had an impact on survival, unexpectedly, repeated HLA mismatching on the HLA-DQ locus was correlated with better survival. Re-transplantations with repeated HLA mismatches did not result in more development of CLAD as compared to recipients without repeated HLA mismatches (p=0.99). Neither the number of repeated HLA mismatched antigens (p=0.52) nor the HLA locus (HLA-A(p=0.34), HLA-B(p=0.97), HLA-C (p=0.80), HLA-DR(p=0.49) and HLA-DQ(p=0.07)) had an impact on the development of CLAD after re-transplantation.

Conclusion: Transplantation with repeated HLA mismatches due to sensitization by a previous transplantation in the absence of detectable HLA-antibodies does not have a negative impact on patient or graft survival.

Keywords: Forbidden antigens; HLA antigens; Lung retransplantation; Repeated HLA mismatch; Unacceptable antigens.

MeSH terms

  • Acute Disease
  • Adult
  • Cohort Studies
  • Cystic Fibrosis / surgery*
  • Female
  • Graft Rejection / immunology*
  • Graft Survival
  • HLA Antigens / immunology
  • Histocompatibility
  • Histocompatibility Testing
  • Humans
  • Immunization
  • Isoantibodies / metabolism
  • Isoantigens / immunology
  • Lung Transplantation*
  • Male
  • Middle Aged
  • Reoperation
  • Retrospective Studies
  • Survival Analysis

Substances

  • HLA Antigens
  • Isoantibodies
  • Isoantigens